DuPont de Nemours, Inc. DD
Throughout this Annual Report on Form 10-K, except as otherwise noted by the context, the terms "DuPont" or "Company" used herein mean DuPont de Nemours, Inc. and its consolidated subsidiaries.
DuPont is a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. The Company is committed to helping customers advance their technology pipelines and provide solutions that address their unique challenges. From delivering clean water to enabling medical packaging solutions which enhance safety and performance, DuPont's innovations power the essential products and technologies people rely on every day. At December 31, 2025, the Company has subsidiaries in about 50 countries worldwide and manufacturing operations in about 20 countries. See Note 23 to the Consolidated Financial Statements for details on the location of the Company's sales and property.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.85B | $6.72B | $6.61B | $13.02B | $12.57B | $11.13B | $15.44B | $16.38B | $11.67B | $48.16B |
| Cost of revenue | $4.49B | $4.50B | $4.44B | $8.40B | $7.97B | $7.06B | $10.03B | $11.12B | $9.56B | $37.67B |
| Gross profit | $2.36B | $2.22B | $2.17B | $4.62B | $4.59B | $4.07B | $5.41B | $20.64B | $12.69B | $10.52B |
| R&D | $193.0M | $203.0M | $192.0M | $536.0M | $557.0M | $565.0M | $689.0M | $797.0M | $657.0M | $1.59B |
| SG&A | $1.02B | $976.0M | $891.0M | $1.47B | $1.60B | $1.49B | $2.06B | $2.40B | $1.61B | $2.95B |
| Pre-tax income | $200.0M | $117.0M | -$279.0M | $1.45B | $1.44B | -$1.26B | -$126.0M | -$135.0M | -$1.52B | $4.41B |
| Income tax | $102.0M | $213.0M | $217.0M | $387.0M | $237.0M | $90.0M | $2.0M | $50.0M | $1.76B | $9.0M |
| Net income | $88.0M | $703.0M | $423.0M | $5.87B | $6.47B | -$2.95B | $498.0M | $3.85B | $1.16B | $4.32B |
| EPS, basic | -1.87 | 1.68 | 0.94 | 11.77 | 11.92 | -4.01 | 0.67 | 4.99 | 2.18 | 3.57 |
| EPS, diluted | -1.86 | 1.68 | 0.94 | 11.75 | 11.89 | -4.01 | 0.67 | 4.99 | 2.15 | 3.52 |
| Shares, diluted (wtd. avg.) | $419.2M | $419.2M | $449.9M | $499.4M | $544.2M | $735.5M | $746.3M | $767.0M | $532.7M | $1.12B |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $715.0M | $1.79B | $2.75B | $3.72B | $2.04B | $8.73B | $1.52B | $8.58B | $14.02B | $6.62B |
| Short-term investments | — | — | $0 | $1.30B | $0 | — | $0 | $29.0M | $956.0M | $0 |
| Receivables | $910.0M | $789.0M | $1.51B | $1.57B | $1.61B | $1.85B | $2.95B | $2.89B | $11.31B | $4.67B |
| Inventory | $1.17B | $1.13B | $2.15B | $2.33B | $2.09B | $2.39B | $4.32B | $4.11B | $16.99B | $7.36B |
| Total current assets | $5.58B | $20.77B | $7.51B | $11.27B | $14.30B | $29.01B | $10.00B | $126.66B | $49.89B | $23.66B |
| Property, plant and equipment | — | — | — | — | — | $9.98B | $10.14B | $9.92B | $36.25B | $23.49B |
| Goodwill | $7.92B | $7.56B | $7.66B | $16.66B | $16.98B | $16.04B | $22.14B | $34.50B | $34.82B | $15.27B |
| Other intangibles | $2.94B | $3.18B | $5.81B | $5.50B | $6.22B | $8.07B | $13.59B | $14.65B | $33.27B | $6.03B |
| Total assets | $21.57B | $36.64B | $38.55B | $41.35B | $45.71B | $70.90B | $69.35B | $187.85B | $191.91B | $79.51B |
| Accounts payable | $995.0M | $1.05B | $1.68B | $2.10B | $2.10B | $2.22B | $2.93B | $2.62B | — | — |
| Short-term debt | $0 | $1.85B | $0 | $300.0M | $150.0M | $1.0M | $3.83B | $15.0M | $1.95B | $272.0M |
| Total current liabilities | $2.31B | $5.50B | $3.10B | $3.73B | $4.93B | $12.23B | $8.35B | $73.31B | $26.13B | $12.60B |
| Long-term debt | — | — | $7.86B | $8.14B | $10.63B | $15.61B | -$15.62B | -$12.63B | $32.12B | $21.09B |
| Total liabilities | $7.47B | $12.84B | $13.83B | $14.34B | $18.66B | $31.83B | $27.79B | $91.95B | — | — |
| Retained earnings | -$24.28B | -$23.08B | -$22.87B | -$21.07B | -$23.19B | -$11.59B | -$8.40B | $30.26B | $29.21B | $30.34B |
| Total equity | $13.92B | $23.35B | $24.73B | $27.02B | $27.05B | $39.07B | $41.56B | $95.90B | $101.65B | $27.25B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $560.0M | $765.0M | $845.0M | $1.25B | $1.85B | $4.09B | $1.41B | $4.73B | -$765.0M | -$2.96B |
| Depreciation and amortisation | $647.0M | $635.0M | $580.0M | $1.14B | $1.11B | $3.09B | $3.19B | $1.54B | $1.06B | $2.86B |
| Stock-based compensation | $38.0M | $56.0M | $57.0M | $75.0M | — | — | — | — | — | — |
| Capital expenditure | $333.0M | $285.0M | $302.0M | $662.0M | $788.0M | $1.19B | $2.47B | $1.24B | $551.0M | $3.80B |
| Investing cash flow | -$374.0M | -$562.0M | $481.0M | $9.00B | -$2.30B | -$202.0M | -$2.31B | -$2.46B | $14.32B | $5.09B |
| Financing cash flow | -$1.75B | -$1.83B | -$2.96B | -$7.65B | -$7.59B | $3.24B | -$11.55B | -$1.92B | -$6.55B | -$4.01B |
| Dividends paid | $597.0M | $635.0M | $651.0M | $652.0M | $630.0M | $882.0M | $1.61B | $3.49B | $3.39B | $2.46B |
| Buybacks | $400.0M | $400.0M | $1.60B | $3.73B | $2.14B | $232.0M | $2.33B | $4.42B | $1.00B | $916.0M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-151204.
Others in SIC 2821
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| DOW | DOW INC. | $21.22B | — | -7.0% |
| ALB | ALBEMARLE CORP | $14.90B | — | -4.4% |
| EMN | EASTMAN CHEMICAL CO | $8.14B | 17.4x | -6.7% |
| HXL | HEXCEL CORP /DE/ | $6.96B | — | -0.5% |
| AVNT | AVIENT CORP | $3.98B | 48.8x | 0.6% |
| ROG | ROGERS CORP | $2.28B | — | -2.3% |
| PCT | PureCycle Technologies, Inc. | $1.28B | — | — |
| ASIX | AdvanSix Inc. | $471.2M | 9.7x | 0.3% |